| Treatment-related adverse events of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis Y Wang, S Zhou, F Yang, X Qi, X Wang, X Guan, C Shen, N Duma, ... JAMA oncology 5 (7), 1008-1019, 2019 | 643 | 2019 |
| Representation of minorities and women in oncology clinical trials: review of the past 14 years N Duma, J Vera Aguilera, J Paludo, CL Haddox, M Gonzalez Velez, ... Journal of oncology practice 14 (1), e1-e10, 2018 | 320 | 2018 |
| Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma L Sanchez, Y Wang, DS Siegel, ML Wang Journal of hematology & oncology 9, 1-8, 2016 | 200 | 2016 |
| 18F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer LB Chen, JL Tong, HZ Song, H Zhu, YC Wang World journal of gastroenterology: WJG 13 (37), 5025, 2007 | 114 | 2007 |
| Modularized functions of the Fanconi anemia core complex Y Huang, JWC Leung, M Lowery, N Matsushita, Y Wang, X Shen, ... Cell reports 7 (6), 1849-1857, 2014 | 112 | 2014 |
| Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients YC Wang, ZH Yu, C Liu, LZ Xu, W Yu, J Lu, RM Zhu, GL Li, XY Xia, ... World journal of gastroenterology: WJG 14 (19), 3074, 2008 | 109 | 2008 |
| Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network DC Weber, Y Wang, R Miller, S Villa, R Zaucha, A Pica, P Poortmans, ... Neuro-oncology 17 (4), 588-595, 2015 | 102 | 2015 |
| FANCM and FAAP24 maintain genome stability via cooperative as well as unique functions Y Wang, JW Leung, Y Jiang, MG Lowery, H Do, KM Vasquez, J Chen, ... Molecular cell 49 (5), 997-1009, 2013 | 101 | 2013 |
| Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center Y Wang, MA Tschautscher, KG Rabe, TG Call, JF Leis, SS Kenderian, ... Haematologica 105 (3), 765, 2020 | 95 | 2020 |
| Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair JWC Leung, Y Wang, KW Fong, MSY Huen, L Li, J Chen Proceedings of the National Academy of Sciences 109 (12), 4491-4496, 2012 | 93 | 2012 |
| Endothelial cells promote triple‐negative breast cancer cell metastasis via PAI‐1 and CCL5 signaling W Zhang, J Xu, H Fang, L Tang, W Chen, Q Sun, Q Zhang, F Yang, Z Sun, ... The FASEB Journal 32 (1), 276-288, 2018 | 88 | 2018 |
| Association of sex, age, and eastern cooperative oncology group performance status with survival benefit of cancer immunotherapy in randomized clinical trials: a systematic … F Yang, SN Markovic, JR Molina, TR Halfdanarson, LC Pagliaro, ... JAMA Network Open 3 (8), e2012534-e2012534, 2020 | 86 | 2020 |
| Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis HA Hill, X Qi, P Jain, K Nomie, Y Wang, S Zhou, ML Wang Blood advances 4 (13), 2927-2938, 2020 | 83 | 2020 |
| Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer Y Wang, Z Yu, T Wang, J Zhang, L Hong, L Chen Lung cancer 56 (2), 289-294, 2007 | 82 | 2007 |
| A ubiquitin-binding protein, FAAP20, links RNF8-mediated ubiquitination to the Fanconi anemia DNA repair network Z Yan, R Guo, M Paramasivam, W Shen, C Ling, D Fox, Y Wang, ... Molecular cell 47 (1), 61-75, 2012 | 77 | 2012 |
| Intratumor heterogeneity predicts metastasis of triple-negative breast cancer F Yang, Y Wang, Q Li, L Cao, Z Sun, J Jin, H Fang, A Zhu, Y Li, W Zhang, ... Carcinogenesis 38 (9), 900-909, 2017 | 71 | 2017 |
| p27Kip1 as a prognostic factor in breast cancer: a systematic review and meta‐analysis X Guan, Y Wang, R Xie, L Chen, J Bai, J Lu, MT Kuo Journal of cellular and molecular medicine 14 (4), 944-953, 2010 | 70 | 2010 |
| Targeting Bruton's tyrosine kinase with ibrutinib in B‐cell malignancies Y Wang, LL Zhang, RE Champlin, ML Wang Clinical Pharmacology & Therapeutics 97 (5), 455-468, 2015 | 69 | 2015 |
| Maintenance therapy with immunomodulatory drugs in multiple myeloma: a meta-analysis and systematic review Y Wang, F Yang, Y Shen, W Zhang, J Wang, VT Chang, BS Andersson, ... Journal of the National Cancer Institute 108 (3), djv342, 2016 | 62 | 2016 |
| Late relapses in patients with diffuse large B-cell lymphoma treated with immunochemotherapy Y Wang, U Farooq, BK Link, MC Larson, RL King, MJ Maurer, C Allmer, ... Journal of clinical oncology 37 (21), 1819, 2019 | 61 | 2019 |
